Course Information

9th Annual UCLA Sleep CME Course:
State-of-the-Art in Sleep Medicine

NRB Auditorium, UCLA Campus
Los Angeles, California

December 05, 2015

Download: [ PDF ]

Physicians in all areas of medicine encounter patients who complain of disturbed sleep. The purpose of this course, the 9th in its series, is to provide clinicians with the knowledge needed to recognize and treat major sleep disorders as they present during the life cycle of the patient from infancy to childhood, adolescence, adulthood and old age. Discussion of sleep problems unique to each age group will be presented including chronic insomnia, excessive sleepiness, sleep apnea, narcolepsy, parasomnias and restless legs syndrome (RLS). Attendees will acquire skills needed in the recognition, evaluation and management of the major sleep disorders they are likely to encounter during routine clinical practice. A major goal of the course is to provide practitioners with current updates and clinical pearls in disturbances of sleep. The course will include an overview of insomnia, narcolepsy, sleep apnea, parasomnias and restless legs syndrome. Each presentation of the primary sleep disorder will be followed by a clinical summary of the treatment options.

Target Audience

This course will target clinicians and health care providers who regularly encounter patients with sleep complaints. Given the focus this year on sleep disturbances across the lifecycle of the patients, the course is particularly useful to family physicians, primary care physicians, pediatricians, obstetricians and gynecologists, geriatric medicine specialists, psychiatrics and other specialists who are likely to encounter patients with sleep disturbances.

Enrollment

Enrollment in this seminar is limited, so we suggest you enroll early.

Online

To enroll click here

By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
9th Annual UCLA Sleep CME Course: State-of-the-Art in Sleep Medicine
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512


By FAX

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your MasterCard, VISA, American Express or Discover. Call (310) 794-2620.

Registration Fee

  • $85.00

Saturday, December 5, 2015

7:50 - 8:00 am Welcome and Introduction
Alon Y. Avidan, MD, MPH
8:00 - 8:45 Sleep Disturbances in Childhood and Adolescents: Insomnias and Hypersomnias
Gary Feldman, MD
8:45 - 9:30 "Last night I didn't get to sleep": Pharmacological and Behavioral Therapies for Insomnia
Leslie Lundt, MD
9:30 - 10:15 "Obstructive Sleep Apnea- What Lies Beneath"
Daniel Kang, MD
10:15 - 10:30 Break
10:30 - 11:15 "Sleep Disorders in Older Age"
Sonia Ancoli-Israel, PhD
11:15 - 12:00 "Parasomnias and Things That Go Bump in the Night."
Alon Y. Avidan, MD, MPH
12:00 - 12:30 pm Q & A with Faculty
12:30 Adjourn

At the conclusion of this activity, participants will be able to:

  • Identify the causes of sleepiness in children, adults and older persons.
  • Identify issues and challenges in the diagnosis/treatment of pediatric sleep disorders.
  • Implement the pharmacological and behavioral management of insomnia, sleep apnea, narcolepsy, restless leg syndrome and circadian rhythm disorders.
  • Discuss the fact that insomnia is often comorbid with medical psychiatric complaints.
  • Apply a practical approach for management of the major sleep disorders in adults including insomnia, obstructive sleep apnea and abnormal motor activity during sleep, including restless legs syndrome.
  • Describe the management of excessive sleepiness in the setting of hypersomnia including narcolepsy.
  • Identify the causes of sleep problems and their potential treatments in children, pregnancy, menopause and in patients with neurodegenerative disorders.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.